BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31791289)

  • 41. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
    Oishi K; Koyanagi S; Matsunaga N; Kadota K; Ikeda E; Hayashida S; Kuramoto Y; Shimeno H; Soeda S; Ohdo S
    Mol Pharmacol; 2010 Jul; 78(1):135-41. PubMed ID: 20400680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras.
    Lai WY; Wang WY; Chang YC; Chang CJ; Yang PC; Peck K
    Biomaterials; 2014 Mar; 35(9):2905-14. PubMed ID: 24397988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
    Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS/MS.
    Chen A; Zhang Y; Sun D; Xu Y; Guo Y; Wang X
    J Pharm Biomed Anal; 2021 Feb; 194():113763. PubMed ID: 33279296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of bezafibrate on the expression of endothelial nitric oxide synthase gene and its mechanisms in cultured bovine endothelial cells.
    Wang Y; Wang Y; Yang Q; Yan JT; Zhao C; Cianflone K; Wang DW
    Atherosclerosis; 2006 Aug; 187(2):265-73. PubMed ID: 16256120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
    Tauber Z; Koleckova M; Cizkova K
    Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: a novel cyclooxygenase-inhibition-independent effect.
    Kato T; Fujino H; Oyama S; Kawashima T; Murayama T
    Biochem Pharmacol; 2011 Dec; 82(11):1781-91. PubMed ID: 21840302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apatinib induces 3-hydroxybutyric acid production in the liver of mice by peroxisome proliferator-activated receptor α activation to aid its antitumor effect.
    Feng S; Wang H; Wang Y; Sun R; Xie Y; Zhou Z; Wang H; Aa J; Zhou F; Wang G
    Cancer Sci; 2019 Oct; 110(10):3328-3339. PubMed ID: 31429167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
    Panigrahy D; Edin ML; Lee CR; Huang S; Bielenberg DR; Butterfield CE; Barnés CM; Mammoto A; Mammoto T; Luria A; Benny O; Chaponis DM; Dudley AC; Greene ER; Vergilio JA; Pietramaggiori G; Scherer-Pietramaggiori SS; Short SM; Seth M; Lih FB; Tomer KB; Yang J; Schwendener RA; Hammock BD; Falck JR; Manthati VL; Ingber DE; Kaipainen A; D'Amore PA; Kieran MW; Zeldin DC
    J Clin Invest; 2012 Jan; 122(1):178-91. PubMed ID: 22182838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.
    Yen WC; Prudente RY; Corpuz MR; Negro-Vilar A; Lamph WW
    Br J Cancer; 2006 Mar; 94(5):654-60. PubMed ID: 16495926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deciphering the Role of Fatty Acid-Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug Target.
    Jia H; Brixius B; Bocianoski C; Ray S; Koes DR; Brixius-Anderko S
    Drug Metab Dispos; 2024 Jan; 52(2):69-79. PubMed ID: 37973374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells.
    Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S
    Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Müller cell cytochrome P450 2c44 in murine retinal angiogenesis.
    Hu J; Geyer A; Dziumbla S; Awwad K; Zeldin DC; Schunck WH; Popp R; Frömel T; Fleming I
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():93-102. PubMed ID: 28442442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
    Oishi K; Uchida D; Ishida N
    FEBS Lett; 2008 Oct; 582(25-26):3639-42. PubMed ID: 18840432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.